https://www.hmpgloballearningnetwork.com/site/cathlab/press-release/reva-medical-announces-positive-motiv-btk-trial-results-showing
REVA Medical Announces Positive MOTIV BTK Trial Results Showing Superiority in Critical...
The MOTIV BTK trial met both its primary safety and efficacy endpoints, demonstrating that the MOTIV scaffold provides a statistically significant improvement...
reva medicaltrial resultsannouncespositivemotiv
https://www.adnkronos.com/immediapress/eng/reva-medical-announces-positive-motiv-btk-trial-results-showing-superiority-in-patients-with-critical-limb-threatening-ischemia_6h0eYvbFQN3iAMYOk4Dg71
REVA Medical Announces Positive MOTIV BTK Trial Results Showing Superiority in Patients with...
MOTIV BTK randomized trial met primary efficacy endpoint, with early and sustained clinical benefit in a complex patient population
reva medicaltrial resultsin patientsannouncespositive